Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy

Epilepsy Research
Linda HoltmanJan A Gorter

Abstract

Status epilepticus (SE) leads to upregulation of pro-inflammatory proteins including cyclooxygenase-2 (cox-2) which could be implicated in the epileptogenic process and epileptic seizures. Recent studies show that cox-2 can regulate expression of P-glycoprotein (P-gp) during epileptogenesis and epilepsy. P-gp could cause pharmacoresistance by reducing brain entry of anti-epileptic drugs such as phenytoin (PHT). Here we have investigated the effects of cox-2 inhibition on epileptogenesis, spontaneous seizures and PHT treatment in a rat model for temporal lobe epilepsy (TLE). A 3-day treatment with the cox-2 inhibitor SC-58236 (SC) was started 1 day before electrically induced SE. Chronic epileptic rats were treated with SC for 14 days, which was followed by a 7-day period of SC/PHT combination treatment. Seizure activity was monitored continuously using electroencephalography. SC treatment did not affect SE duration, but led to an increased number of rats that died during the first 2 weeks after SE. Cox-2 inhibition during the chronic period led to an increased number of seizures in the 2nd week of treatment in 50% of the rats. SC/PHT treatment reduced seizures significantly for only 2 days. Both SC treatment that started before...Continue Reading

References

Mar 1, 1972·Electroencephalography and Clinical Neurophysiology·R J Racine
Feb 7, 2001·Proceedings of the National Academy of Sciences of the United States of America·C IadecolaM E Ross
Aug 20, 2004·Pharmacological Reviews·Daniel L SimmonsTimothy Hla
Nov 24, 2005·Epilepsia·Annamaria Vezzani, Tiziana Granata
Sep 12, 2006·The Journal of Pharmacology and Experimental Therapeutics·Sandra J HewettJames A Hewett
Feb 13, 2008·Epilepsia·Erwin A van VlietJan A Gorter
Jun 6, 2009·The Journal of Pharmacology and Experimental Therapeutics·Anton PekcecHeidrun Potschka

❮ Previous
Next ❯

Citations

May 13, 2011·Epilepsia·Alon Friedman, Ray Dingledine
Mar 29, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Rafal M KaminskiHenrik Klitgaard
Sep 10, 2014·Mediators of Inflammation·Tadayuki ShimadaKanato Yamagata
Mar 27, 2013·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Keisuke YoshikawaAtsuyoshi Shimada
Jan 23, 2014·Epilepsia·Asheebo RojasRaymond Dingledine
Jun 19, 2012·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Gustavo SilveiraAntonio Lucio Teixeira
Jan 25, 2011·Lancet Neurology·Asla Pitkänen, Katarzyna Lukasiuk
Apr 30, 2014·Journal of Medicinal Chemistry·Thota GaneshRay Dingledine
Jan 7, 2014·The European Journal of Neuroscience·Pascal BielefeldCarlos P Fitzsimons
Apr 12, 2016·Trends in Pharmacological Sciences·Avijit DeyJianxiong Jiang
Apr 24, 2012·Neuropharmacology·Annamaria VezzaniRaymond J Dingledine
May 3, 2015·Pharmacological Reports : PR·Iwona RadzikStanisław J Czuczwar
Sep 6, 2013·Experimental Neurology·Jee-In ChungEun Joo Baik
Dec 7, 2017·Reviews in the Neurosciences·Sree LalithaBikash Medhi
Feb 27, 2013·The Korean Journal of Physiology & Pharmacology : Official Journal of the Korean Physiological Society and the Korean Society of Pharmacology·Kyoung Hoon JeongSeong Yun Kim
Nov 30, 2018·Expert Opinion on Therapeutic Targets·Asheebo RojasRaymond Dingledine
Jul 3, 2019·Nature Reviews. Neurology·Annamaria VezzaniTeresa Ravizza
Nov 2, 2019·Journal of Neuroinflammation·Chitra RawatRitushree Kukreti
Oct 29, 2019·Behavioural Pharmacology·Amal Mohamed Mahfoz, Naiyer Shahzad
Feb 25, 2018·Pharmacological Reports : PR·Krzysztof ŁukawskiStanisław J Czuczwar
Apr 2, 2020·International Journal of Molecular Sciences·Barbara MiziakStanisław J Czuczwar
Oct 30, 2019·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Anika M S HartzBjoern Bauer
Jul 29, 2020·Neurochemical Research·Ferit DurankuşOytun Erbaş
Dec 7, 2018·Expert Opinion on Investigational Drugs·Ashish Dhir
Nov 30, 2016·Frontiers in Neurology·Patrícia Gonçalves BarbalhoClaudia Vianna Maurer-Morelli
May 17, 2018·Journal of Neuroinflammation·Amna Rana, Alberto E Musto
Jun 17, 2020·Pharmacological Reviews·Wolfgang LöscherAnnamaria Vezzani
Oct 5, 2020·Seizure : the Journal of the British Epilepsy Association·Iqra Mukhtar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.